Efficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus : Results from the randomized, phase 2 LUNA study

Ferolla, P. (author)

Umbria Reg Canc Network, Multidisciplinary NET Grp, Dept Med Oncol, Perugia, Italy.;Univ Perugia, Perugia, Italy.

Brizzi, M. P. (author)

Univ Turin, Dept Oncol, Turin, Italy.

Meyer, T. (author)

Royal Free Hosp, Oncol, London, England.;UCL, London, England.

show more...

Mansoor, W. (author)

Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England.

Mazieres, J. (author)

Hop Larrey, CHU Toulouse, Med Oncol, Toulouse, France.

Cao, C. D. (author)

CHRU Lille, Med Oncol, Lille, France.

Lena, H. (author)

Ctr Hosp Univ, Pneumol, Rennes, France.

Berruti, A. (author)

Univ Brescia, Med Oncol, Brescia, Italy.

Damiano, V. (author)

Azienda Osped Univ Policlin Federico II AOU Feder, Dept Dip Oncol, Endocr Mol Clin, Naples, Italy.

Buikhuisen, W. (author)

Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.

Stankovic, M. (author)

Novartis Pharma Serv Inc, Med Affairs, Novi Beograd, Serbia.

Singh, N. (author)

Cognizant Technol Solut, PLS Clin Project Mgt, Bombay, Maharashtra, India.

Chiodini, E. (author)

Parexel, Clin, Origgio, Italy.

Gislimberti, G. (author)

OORE GMO, Gislimberti, Origgio, Italy.

Öberg, Kjell E., 1946- (author)

Uppsala universitet,Endokrin tumörbiologi

Baudin, E. (author)

Inst Gustave Roussy, Endocrinol, Villejuif, France.

show less...

Umbria Reg Canc Network, Multidisciplinary NET Grp, Dept Med Oncol, Perugia, Italy;Univ Perugia, Perugia, Italy. Univ Turin, Dept Oncol, Turin, Italy. (creator_code:org_t)

2016

2016

English.

In: Annals of Oncology. - 0923-7534 .- 1569-8041. ; 27:6

Related links:

https://urn.kb.se/re...

• Journal article (peer-reviewed)